Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis.
| Autor: | van Velzen M; Department of Viroscience, Erasmus MC., van de Vijver DA, van Loenen FB, Osterhaus AD, Remeijer L, Verjans GM |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The Journal of infectious diseases [J Infect Dis] 2013 Nov 01; Vol. 208 (9), pp. 1359-65. Date of Electronic Publication: 2013 Jul 30. |
| DOI: | 10.1093/infdis/jit350 |
| Abstrakt: | Purpose: Long-term acyclovir (ACV) prophylaxis, recommended to prevent recurrent herpes simplex virus type 1 (HSV-1) ocular disorders, may pose a risk for ACV-refractory disease due to ACV resistance. We determined the effect of ACV prophylaxis on the prevalence of corneal ACV-resistant (ACV(R)) HSV-1 and clinical consequences thereof in patients with recurrent HSV-1 keratitis (rHK). Methods: Frequencies of ACV(R) viruses were determined in 169 corneal HSV-1 isolates from 78 rHK patients with a history of stromal disease. The isolates' ACV susceptibility profiles were correlated with clinical parameters to identify risk factors predisposing to ACV(R) rHK. Results: Corneal HSV-1 isolates with >28% ACV(R) viruses were defined as ACV(R) isolates. Forty-four isolates (26%) were ACV-resistant. Multivariate analyses identified long-term ACV prophylaxis (≥12 months) (odds ratio [OR] 3.42; 95% confidence interval [CI], 1.32-8.87) and recurrence duration of ≥45 days (OR 2.23; 95% CI, 1.02-4.87), indicative of ACV-refractory disease, as independent risk factors for ACV(R) isolates. Moreover, a corneal ACV(R) isolate was a risk factor for ACV-refractory disease (OR 2.28; 95% CI, 1.06-4.89). Conclusions: The data suggest that long-term ACV prophylaxis predisposes to ACV-refractory disease due to the emergence of corneal ACV(R) HSV-1. ACV-susceptibility testing is warranted during follow-up of rHK patients. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|